Fund moves
86 tracked managers disclosed the same change for Q1 2026. From a 13F filed Aug 26, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Planned for Aug 5, 2026 · Notice filed Aug 5, 2026
A Merck officer told the SEC about a plan to sell $6.81M of Merck shares around Aug 5, 2026. The filing says the shares were acquired as compensation.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
None found in footnotes
Only flagged when a footnote says so; never inferred
Fund moves
86 tracked managers disclosed the same change for Q1 2026. From a 13F filed Aug 26, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
114 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 25, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
114 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 18, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: reported its results, 1 day earlier (Aug 4, 2026). The first one after it: changed a top executive or board member, 65 days later (Oct 9, 2026).